Dilated cardiomyopathy and mitochondrial dysfunction in Sirt1-deficient mice: A role for Sirt1-Mef2 in adult heart

Journal of Molecular and Cellular Cardiology

Volumn 53, Issue 4, 2012, Pages 521-531

  Planavila, A ^a   Dominguez, E ^b   Navarro, M ^b   Vinciguerra, M ^c,d   Iglesias, R ^a   Giralt, M ^a   Lope Piedrafita, S ^b,e   Ruberte, J ^b   Villarroya, F ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITY OF LONDON   (United Kingdom)

^d EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

^e BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

Dilated cardiomyopathy; Mef2; Mitochondrial dysfunction; Sirt1

Indexed keywords

MYOCYTE ENHANCER FACTOR 2; SIRTUIN 1;

ACETYLATION; ADULT ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL SIZE; CELL STRUCTURE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; ENZYME DEFICIENCY; FEMALE; FETUS; GENE; GENE EXPRESSION REGULATION; HEART DEVELOPMENT; HEART DILATATION; HEART FUNCTION; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; IMMUNOBLOTTING; MALE; MITOCHONDRIAL GENE; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; CARDIOMYOPATHY, DILATED; CELLS, CULTURED; HEART; MICE; MICE, KNOCKOUT; MITOCHONDRIA, HEART; MYOCARDIUM; MYOCYTES, CARDIAC; MYOGENIC REGULATORY FACTORS; SIGNAL TRANSDUCTION; SIRTUIN 1;

MUS;

EID: 84865555215     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.07.019     Document Type: Article

References (37)

1. Jefferies J.L., Towbin J.A. Dilated cardiomyopathy. Lancet 2010, 375:752-762.
2. Taha M., Lopaschuk G.D. Alterations in energy metabolism in cardiomyopathies. Ann Med 2007, 39:594-607.
3. Marin-Garcia J., Goldenthal M.J. Understanding the impact of mitochondrial defects in cardiovascular disease: a review. J Card Fail 2002, 8:347-361.
4. Cheng H.L., Mostoslavsky R., Saito S., Manis J.P., Gu Y., Patel P., et al. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci U S A 2003, 100:10794-10799.
5. Vinciguerra M., Fulco M., Ladurner A., Sartorelli V., Rosenthal N. SirT1 in muscle physiology and disease: lessons from mouse models. Dis Model Mech 2010, 3:298-303.
6. Planavila A., Iglesias R., Giralt M., Villarroya F. Sirt1 acts in association with PPAR{alpha} to protect the heart from hypertrophy, metabolic dysregulation, and inflammation. Cardiovasc Res 2011, 90:276-284.
7. Kelly D.P., Strauss A.W. Inherited cardiomyopathies. N Engl J Med 1994, 330:913-919.
8. Wallace D.C. Mitochondrial diseases in man and mouse. Science 1999, 283:1482-1488.
9. Goffart S., von Kleist-Retzow J.C., Wiesner R.J. Regulation of mitochondrial proliferation in the heart: power-plant failure contributes to cardiac failure in hypertrophy. Cardiovasc Res 2004, 64:198-207.
10. Naya F.J., Black B.L., Wu H., Bassel-Duby R., Richardson J.A., Hill J.A., et al. Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor. Nat Med 2002, 8:1303-1309.
11. Planavila A., Laguna J.C., Vazquez-Carrera M. Nuclear factor-kappaB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy. J Biol Chem 2005, 280:17464-17471.
12. de Vries J.E., Vork M.M., Roemen T.H., de Jong Y.F., Cleutjens J.P., van der Vusse G.J., et al. Saturated but not mono-unsaturated fatty acids induce apoptotic cell death in neonatal rat ventricular myocytes. J Lipid Res 1997, 38:1384-1394.
13. Amat R., Planavila A., Chen S.L., Iglesias R., Giralt M., Villarroya F. SIRT1 controls the transcription of the peroxisome proliferator-activated receptor-gamma Co-activator-1alpha (PGC-1alpha) gene in skeletal muscle through the PGC-1alpha autoregulatory loop and interaction with MyoD. J Biol Chem 2009, 284:21872-21880.
14. McBurney M.W., Yang X., Jardine K., Hixon M., Boekelheide K., Webb J.R., et al. The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis. Mol Cell Biol 2003, 23:38-54.
15. Borgarelli M., Tarducci A., Zanatta R., Haggstrom J. Decreased systolic function and inadequate hypertrophy in large and small breed dogs with chronic mitral valve insufficiency. J Vet Intern Med 2007, 21:61-67.
16. Levine B., Kalman J., Mayer L., Fillit H.M., Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990, 323:236-241.
17. Thaik C.M., Calderone A., Takahashi N., Colucci W.S. Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes. J Clin Invest 1995, 96:1093-1099.
18. Hansson A., Hance N., Dufour E., Rantanen A., Hultenby K., Clayton D.A., et al. A switch in metabolism precedes increased mitochondrial biogenesis in respiratory chain-deficient mouse hearts. Proc Natl Acad Sci U S A 2004, 101:3136-3141.
19. Mercy L., Pauw A., Payen L., Tejerina S., Houbion A., Demazy C., et al. Mitochondrial biogenesis in mtDNA-depleted cells involves a Ca2+dependent pathway and a reduced mitochondrial protein import. FEBS J 2005, 272:5031-5055.
20. Ramachandran B., Yu G., Gulick T. Nuclear respiratory factor 1 controls myocyte enhancer factor 2A transcription to provide a mechanism for coordinate expression of respiratory chain subunits. J Biol Chem 2008, 283:11935-11946.
21. Potthoff M.J., Olson E.N. MEF2: a central regulator of diverse developmental programs. Development 2007, 134:4131-4140.
22. Ma K., Chan J.K., Zhu G., Wu Z. Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation. Mol Cell Biol 2005, 25:3575-3582.
23. Xu J., Gong N.L., Bodi I., Aronow B.J., Backx P.H., Molkentin J.D. Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice. J Biol Chem 2006, 281:9152-9162.
24. Bouras T., Fu M., Sauve A.A., Wang F., Quong A.A., Perkins N.D., et al. SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1. J Biol Chem 2005, 280:10264-10276.
25. Alcendor R.R., Gao S., Zhai P., Zablocki D., Holle E., Yu X., et al. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res 2007, 100:1512-1521.
26. Sundaresan N.R., Pillai V.B., Wolfgeher D., Samant S., Vasudevan P., Parekh V., et al. The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy. Sci Signal 2011, 4:ra46.
27. Boily G., Seifert E.L., Bevilacqua L., He X.H., Sabourin G., Estey C., et al. SirT1 regulates energy metabolism and response to caloric restriction in mice. PLoS One 2008, 3:e1759.
28. Wei Y.H., Lee H.C. Mitochondrial DNA mutations and oxidative stress in mitochondrial diseases. Adv Clin Chem 2003, 37:83-128.
29. Graham B.H., Waymire K.G., Cottrell B., Trounce I.A., MacGregor G.R., Wallace D.C. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nat Genet 1997, 16:226-234.
30. Rodgers J.T., Lerin C., Haas W., Gygi S.P., Spiegelman B.M., Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005, 434:113-118.
31. Gerhart-Hines Z., Rodgers J.T., Bare O., Lerin C., Kim S.H., Mostoslavsky R., et al. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J 2007, 26:1913-1923.
32. Lin J., Handschin C., Spiegelman B.M. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 2005, 1:361-370.
33. Zhao X., Sternsdorf T., Bolger T.A., Evans R.M., Yao T.P. Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications. Mol Cell Biol 2005, 25:8456-8464.
34. Nakagawa Y., Kuwahara K., Takemura G., Akao M., Kato M., Arai Y., et al. p300 plays a critical role in maintaining cardiac mitochondrial function and cell survival in postnatal hearts. Circ Res 2009, 105:746-754.
35. Feige J.N., Auwerx J. Transcriptional targets of sirtuins in the coordination of mammalian physiology. Curr Opin Cell Biol 2008, 20:303-309.
36. De L.A., Severino A., De P.P., Cottone G., De L.L., De F.M., et al. p300/cAMP-response-element-binding-protein ('CREB')-binding protein (CBP) modulates co-operation between myocyte enhancer factor 2A (MEF2A) and thyroid hormone receptor-retinoid X receptor. Biochem J 2003, 369:477-484.
37. Sun H., Yang X., Zhu J., Lv T., Chen Y., Chen G., et al. Inhibition of p300-HAT results in a reduced histone acetylation and down-regulation of gene expression in cardiac myocytes. Life Sci 2010, 87:707-714.